Glaxosmithkline, Theravance Intend to File Relvar Ellipta for COPD in Japan
September 24, 2015 at 05:28 AM EDT
GlaxoSmithKline (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the intention to file a supplemental Japanese New ...